Citation Impact

Citing Papers

Tumour-cell invasion and migration: diversity and escape mechanisms
2003 Standout
ROS stress in cancer cells and therapeutic implications
2004 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
The third dimension bridges the gap between cell culture and live tissue
2007 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Fibroblasts Contribute to Melanoma Tumor Growth and Drug Resistance
2011
Cancer Metastasis: Building a Framework
2006 Standout
Drug resistance and the microenvironment: nature and nurture
2003
The biology and function of fibroblasts in cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Collective cell migration in morphogenesis, regeneration and cancer
2009 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Tumour-microenvironmental interactions: paths to progression and targets for treatment
2010
Carbonic Anhydrase II Mediates Malignant Behavior of Pulmonary Neuroendocrine Tumors
2014
Cell Migration: Integrating Signals from Front to Back
2003 StandoutScience
Combination therapy in combating cancer
2017 Standout
CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells
2005
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells
2006
Analysis of nanoparticle delivery to tumours
2016 Standout
Perspectives on medicinal properties of plumbagin and its analogs
2010 Standout

Works of Hannah Specht being referenced

In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways
2002
Rankless by CCL
2026